JYNTNasdaqPatent Owners & LessorsFiscal year ends December 31
JOINT Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$7.27+0.24 (+3.41%)
Close on Oct 19, 2026
- Market cap
- $103.58M
- P/E (TTM)
- 26.9
- Dividend yield
- –
JOINT Corp revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Franchise Operations | $58.55M | $56.64M | $54.90M | $54.44M | $53.72M | $53.06M | $52.16M | $50.16M | $49.10M | $47.99M | $46.98M | $45.46M | 100.0% | +9.0% |
| Corporate clinics | – | – | – | – | – | – | – | $70.64M | $70.97M | $71.13M | $70.72M | $69.30M | – | – |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Franchise Operations | – | – | – | – | – | – | – | $21.28M | $20.83M | $21.13M | $20.33M | $19.65M | – |
| Corporate clinics | – | – | – | – | – | – | – | -$2.66M | -$864.39K | -$593.68K | -$2.50M | -$1.57M | – |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Royalty fees | $33.36M | $33.17M | $33.20M | $33.15M | $32.92M | $32.63M | $32.14M | $31.28M | $30.56M | $29.88M | $29.16M | $28.35M | 57.0% | +1.4% |
| Advertising fund revenue | $13.17M | $11.79M | $10.45M | $9.51M | $9.41M | $9.32M | $9.18M | $8.93M | $8.73M | $8.54M | $8.32M | $8.08M | 22.5% | +40.0% |
| Software fees | $6.18M | $6.11M | $6.04M | $5.94M | $5.83M | $5.76M | $5.69M | $5.57M | $5.44M | $5.26M | $5.09M | $4.87M | 10.5% | +6.0% |
| Franchise and regional developer | $3.67M | $3.69M | $3.37M | $3.49M | $3.22M | $3.17M | $3.00M | $2.78M | $2.83M | $2.78M | $2.88M | $2.65M | 6.3% | +14.0% |
| Other revenues | $2.17M | $1.88M | $1.83M | $2.35M | $2.34M | $2.17M | $2.15M | $1.59M | $1.53M | $1.52M | $1.53M | $2.21M | 3.7% | -7.3% |
| Company clinics | – | – | – | – | – | – | – | $70.64M | $70.97M | $71.13M | $70.72M | $69.30M | – | – |
By region
From the segment and revenue-disaggregation notes of Joint's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.